NXL-001
Asset
- Stage
- Human trials
- Modality
- Not known
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Alzheimer's disease
Human trials, neuexcell.com, 10 Oct 2026
In the full profile
- Owner and partners1
- Competitors3
Every asset’s record: target, stage, trials and the evidence behind it.